Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TRANYLCYPROMINE SULF 10 MG TAB

Tranylcypromine
$0.6280per EA

Strength

10 mg/1

Manufacturer

Novitium Pharma LLC

NDC

70954053810

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TRANYLCYPROMINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206856

On Market Since

6/6/2021

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors

Price History

1W

0.0%

1M

-1.6%

3M

-11.5%

6M

-3.0%

1Y

-12.8%

3Y

-27.8%

5Y

N/A

All

-53.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

PHENELZINE SULFATE 15 MG TAB
Generic
43386036021•Lupin Pharmaceuticals Inc.
$0.5384
per EA
PHENELZINE SULFATE 15 MG TAB
Generic
59762011901•Mylan Pharmaceuticals Inc.
$0.5887
per EA
SELEGILINE HCL 5 MG TABLET
Generic
60505343808•Apotex Corp.
$0.6101
per EA
TRANYLCYPROMINE SULF 10 MG TAB
Generic
00591559001•Actavis Pharma, Inc.
$0.6280
per EA
TRANYLCYPROMINE SULF 10 MG TAB
Generic
43547065510•Solco Healthcare US LLC
$0.6280
per EA
TRANYLCYPROMINE SULF 10 MG TAB
Generic
64380017601•Strides Pharma Inc.
$0.6280
per EA
SELEGILINE HCL 5 MG CAPSULE
Generic
16571065906•Rising Pharma Holdings Inc.
$0.6333
per EA
SELEGILINE HCL 5 MG CAPSULE
Generic
60505005501•Apotex Corp.
$0.6333
per EA
SELEGILINE HCL 5 MG CAPSULE
Generic
60505005502•Apotex Corp.
$0.6333
per EA
SELEGILINE HCL 5 MG CAPSULE
Generic
70954050410•Novitium Pharma LLC
$0.6333
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy